Aktas, M. K. Et Al. 2023. Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm. The Lancet Oncology , vol.24, no.5 .

Aktas, M. K., AYTAÇ, E., YILDIZ, İ., & OZER, L., (2023). Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm. The Lancet Oncology , vol.24, no.5.

Aktas, Melik Et Al. "Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm," The Lancet Oncology , vol.24, no.5, 2023

Aktas, Melik K. Et Al. "Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm." The Lancet Oncology , vol.24, no.5, 2023

Aktas, M. K. Et Al. (2023) . "Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm." The Lancet Oncology , vol.24, no.5.

@article{article, author={Melik Kagan Aktas Et Al. }, title={Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm}, journal={The Lancet Oncology}, year=2023}